# Clinical Performance of Nano Plus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

> **NCT02929030** · — · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 2500 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Nano

## Key facts

- **NCT ID:** NCT02929030
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2018-01
- **Final completion:** 2022-01
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2016-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02929030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02929030, "Clinical Performance of Nano Plus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02929030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
